MY191149A - Oral composition - Google Patents

Oral composition

Info

Publication number
MY191149A
MY191149A MYPI2018701582A MYPI2018701582A MY191149A MY 191149 A MY191149 A MY 191149A MY PI2018701582 A MYPI2018701582 A MY PI2018701582A MY PI2018701582 A MYPI2018701582 A MY PI2018701582A MY 191149 A MY191149 A MY 191149A
Authority
MY
Malaysia
Prior art keywords
oral composition
carbon atoms
sulfonic acid
acid salt
component selected
Prior art date
Application number
MYPI2018701582A
Inventor
Tetsuya Kawaguchi
Natsume Hagimori
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY191149A publication Critical patent/MY191149A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an oral composition comprising (A) an ?-olefin sulfonic acid salt, (B) peppermint oil and (C) components (C-1) and (C-2) shown below, wherein the (C-1)/(C-2) content ratio is 20 to 1,000,000 by weight: (C-1) at least one component selected from lactones each having 6 to 12 carbon atoms; and (C-2) at least one component selected from aldehydes each having 8 to 12 carbon atoms. The oral composition is sustainably reduced in bitterness coming from the ?-olefin sulfonic acid salt and has excellent and long-lasting flavor stability.
MYPI2018701582A 2015-11-30 2016-11-24 Oral composition MY191149A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015233200 2015-11-30
PCT/JP2016/084780 WO2017094582A1 (en) 2015-11-30 2016-11-24 Oral composition

Publications (1)

Publication Number Publication Date
MY191149A true MY191149A (en) 2022-06-01

Family

ID=58796753

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018701582A MY191149A (en) 2015-11-30 2016-11-24 Oral composition

Country Status (5)

Country Link
JP (1) JP6766823B2 (en)
KR (1) KR20180083300A (en)
CN (1) CN108366950B (en)
MY (1) MY191149A (en)
WO (1) WO2017094582A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7031253B2 (en) * 2017-11-29 2022-03-08 ライオン株式会社 Toothpaste composition
WO2019194068A1 (en) 2018-04-06 2019-10-10 ライオン株式会社 ORAL COMPOSITION, AND BITTERNESS AMELIORATION AGENT FOR α-OLEFIN SULFONATES
KR101937321B1 (en) * 2018-09-28 2019-01-10 연세대학교 산학협력단 Composition having anti-stress, anti-depressant or anxiolytic effect comprising at least one compound selected from the group consisting of undecanal, dodecanal, and pharmaceutically acceptable salts thereof as active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004018431A (en) * 2002-06-14 2004-01-22 Kiyomitsu Kawasaki Perfume composition for oral cavity and oral cavity composition containing the same
JP4918973B2 (en) * 2005-08-12 2012-04-18 ライオン株式会社 Dentifrice composition
JP5862195B2 (en) * 2010-12-08 2016-02-16 ライオン株式会社 Oral composition and oral biofilm disinfectant
JP6007781B2 (en) 2011-12-26 2016-10-12 ライオン株式会社 Oral composition and oral biofilm remover
CN105358128B (en) 2013-07-18 2019-03-01 狮王株式会社 Oral biological film remover and composition for oral cavity
JP6318487B2 (en) 2013-07-18 2018-05-09 ライオン株式会社 Oral composition
JP7031253B2 (en) * 2017-11-29 2022-03-08 ライオン株式会社 Toothpaste composition

Also Published As

Publication number Publication date
CN108366950B (en) 2022-02-18
JP6766823B2 (en) 2020-10-14
KR20180083300A (en) 2018-07-20
CN108366950A (en) 2018-08-03
WO2017094582A1 (en) 2017-06-08
JPWO2017094582A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
LT3577110T (en) 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl substituted compounds as hiv inhibitors
WO2016077464A8 (en) Amino acid derivatives and their uses
WO2015160843A8 (en) Ion channel activators and methods of use
TN2018000424A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2019011496A (en) Niraparib compositions.
JO3155B1 (en) Sweet flavor modifier
MX2018003926A (en) Composition for improved performance.
WO2017160116A3 (en) Novel compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
MX2022010755A (en) Kinase inhibitors and uses thereof.
WO2017008136A3 (en) Flourinated cbd compounds, compositions and uses thereof
MX2016008128A (en) Palatability enhancers for pet food, method of preparation and uses thereof.
PH12016502002A1 (en) Novel bacteriophage and composition comprising same
MY191149A (en) Oral composition
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
WO2015173427A3 (en) Rapid-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
WO2016076607A3 (en) Pharmaceutical composition and health functional food, containing a red ginseng concentrate with enriched compound k component, for preventing and treating non-alcoholic fatty liver symptom
PH12016501991A1 (en) Flavouring composition
SA517390095B1 (en) Butadiene Telomerization Catalyst and Preparation Thereof
MX2016013952A (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed.
UA117200C2 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
WO2016189385A3 (en) Enhanced salt compositions and methods of preparation thereof
MY193591A (en) Standardised extract of labisia pumila for weight reduction and nano-formulation thereof
PH12018550048A1 (en) Novel citric acid derivative
MX2018015852A (en) Use of certain compounds to modify, reduce, or eliminate off-notes.